WKP|Q59545708

Search

Select Field:

Select Index:

Search Terms:

Leader		00000nz a2200037n 45 0
001		WKP\|Q59545708 (VIAF cluster) (Authority/Source Record)
003		WKP
005		20241120235827.0
008		241120nneanz\|\|abbn n and d
035		‎‡a (WKP)Q59545708‏
024		‎‡a 0000-0003-2108-8059‏ ‎‡2 orcid‏
024		‎‡a 35309670400‏ ‎‡2 scopus‏
035		‎‡a (OCoLC)Q59545708‏
100	0	‎‡a Benjamin P Davis‏ ‎‡c researcher ORCID ID = 0000-0003-2108-8059‏ ‎‡9 en‏
375		‎‡a 1‏ ‎‡2 iso5218‏
400	0	‎‡a Benjamin P Davis‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670		‎‡a Author's A randomized, double-blind, parallel trial comparing capsaicin nasal spray with placebo in subjects with a significant component of nonallergic rhinitis.‏
670		‎‡a Author's Antigen presentation by eosinophils in eosinophilic esophagitis?‏
670		‎‡a Author's Association of eosinophilic esophagitis and hypertrophic cardiomyopathy.‏
670		‎‡a Author's Asthma screening of inner city and urban elementary school-aged children‏
670		‎‡a Author's Biologic response modifiers: Indications, implications, and insights.‏
670		‎‡a Author's Bronchoalveolar fluid is not a major hindrance to virus-mediated gene therapy in cystic fibrosis.‏
670		‎‡a Author's Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial‏
670		‎‡a Author's Emerging concepts of dietary therapy for pediatric and adult eosinophilic esophagitis‏
670		‎‡a Author's Eosinophils and cancer.‏
670		‎‡a Author's Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease‏
670		‎‡a Author's Is exhaled nitric oxide a useful adjunctive test for assessing asthma?‏
670		‎‡a Author's Mechanisms of Disease of Eosinophilic Esophagitis.‏
670		‎‡a Author's Pathophysiology of Eosinophilic Esophagitis‏
670		‎‡a Author's Profound loss of esophageal tissue differentiation in patients with eosinophilic esophagitis‏
909		‎‡a (scopus) 35309670400‏ ‎‡9 1‏
909		‎‡a (orcid) 0000000321088059‏ ‎‡9 1‏
919		‎‡a eosinophilsandcancer‏ ‎‡A Eosinophils and cancer.‏ ‎‡9 1‏
919		‎‡a isexhalednitricoxideausefuladjunctivetestforassessingasthma‏ ‎‡A Is exhaled nitric oxide a useful adjunctive test for assessing asthma?‏ ‎‡9 1‏
919		‎‡a mechanismsofdiseaseofeosinophilicesophagitis‏ ‎‡A Mechanisms of Disease of Eosinophilic Esophagitis.‏ ‎‡9 1‏
919		‎‡a pathophysiologyofeosinophilicesophagitis‏ ‎‡A Pathophysiology of Eosinophilic Esophagitis‏ ‎‡9 1‏
919		‎‡a efficacyandsafetyofar101inoralimmunotherapyforpeanutallergyresultsofarc001arandomizeddoubleblindplacebocontrolledphase2clinicaltrial‏ ‎‡A Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial‏ ‎‡9 1‏
919		‎‡a genomewideassociationanalysisofeosinophilicesophagitisprovidesinsightintothetissuespecificityofthisallergicdisease‏ ‎‡A Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease‏ ‎‡9 1‏
919		‎‡a bronchoalveolarfluidisnotamajorhindrancetovirusmediatedgenetherapyincysticfibrosis‏ ‎‡A Bronchoalveolar fluid is not a major hindrance to virus-mediated gene therapy in cystic fibrosis.‏ ‎‡9 1‏
919		‎‡a biologicresponsemodifiersindicationsimplicationsandinsights‏ ‎‡A Biologic response modifiers: Indications, implications, and insights.‏ ‎‡9 1‏
919		‎‡a asthmascreeningofinnercityandurbanelementaryschoolagedchildren‏ ‎‡A Asthma screening of inner city and urban elementary school-aged children‏ ‎‡9 1‏
919		‎‡a associationofeosinophilicesophagitisandhypertrophiccardiomyopathy‏ ‎‡A Association of eosinophilic esophagitis and hypertrophic cardiomyopathy.‏ ‎‡9 1‏
919		‎‡a antigenpresentationbyeosinophilsineosinophilicesophagitis‏ ‎‡A Antigen presentation by eosinophils in eosinophilic esophagitis?‏ ‎‡9 1‏
919		‎‡a randomizeddoubleblindparalleltrialcomparingcapsaicinnasalspraywithplaceboinsubjectswithasignificantcomponentofnonallergicrhinitis‏ ‎‡A A randomized, double-blind, parallel trial comparing capsaicin nasal spray with placebo in subjects with a significant component of nonallergic rhinitis.‏ ‎‡9 1‏
919		‎‡a profoundlossofesophagealtissuedifferentiationinpatientswitheosinophilicesophagitis‏ ‎‡A Profound loss of esophageal tissue differentiation in patients with eosinophilic esophagitis‏ ‎‡9 1‏
919		‎‡a emergingconceptsofdietarytherapyforpediatricandadulteosinophilicesophagitis‏ ‎‡A Emerging concepts of dietary therapy for pediatric and adult eosinophilic esophagitis‏ ‎‡9 1‏
946		‎‡a b‏ ‎‡9 1‏
996		‎‡2 LC\|nb2016000097‏
996		‎‡2 ISNI\|000000049848409X‏
996		‎‡2 SUDOC\|279509782‏
996		‎‡2 ISNI\|0000000498914328‏
996		‎‡2 W2Z\|1675320984253‏
996		‎‡2 BIBSYS\|4045715‏
996		‎‡2 ISNI\|0000000109220497‏
996		‎‡2 NSK\|000612102‏
996		‎‡2 DNB\|1233291394‏
996		‎‡2 NYNYRILM\|314615‏
996		‎‡2 BNE\|XX5669171‏
996		‎‡2 NTA\|238583023‏
996		‎‡2 LC\|n 2017065505‏
996		‎‡2 BNF\|18120895‏
996		‎‡2 CAOONL\|ncf10325835‏
996		‎‡2 ISNI\|0000000074521141‏
996		‎‡2 ISNI\|0000000043016839‏
996		‎‡2 LC\|n 84198947‏
996		‎‡2 NII\|DA06345628‏
996		‎‡2 CAOONL\|ncf10832287‏
996		‎‡2 NII\|DA10171892‏
996		‎‡2 ISNI\|0000000366873448‏
996		‎‡2 LC\|n 89646291‏
996		‎‡2 J9U\|987012881941805171‏
996		‎‡2 NUKAT\|n 2012043064‏
996		‎‡2 LIH\|LNB:K_k__o_;=B1‏
996		‎‡2 NLA\|000035033815‏
996		‎‡2 LC\|no2017115360‏
996		‎‡2 CAOONL\|ncf11878631‏
996		‎‡2 RERO\|A003157975‏
996		‎‡2 ISNI\|0000000514247407‏
996		‎‡2 LIH\|LNB:C_l__t_S;=CG‏
996		‎‡2 ISNI\|0000000513484275‏
996		‎‡2 DNB\|118916874‏
996		‎‡2 BNF\|18102869‏
996		‎‡2 RERO\|A027096678‏
996		‎‡2 CAOONL\|ncf11466342‏
996		‎‡2 LC\|no2012029265‏
996		‎‡2 J9U\|987012800158205171‏
996		‎‡2 PLWABN\|9812842438705606‏
996		‎‡2 NUKAT\|n 2019012466‏
996		‎‡2 ISNI\|0000000035640543‏
996		‎‡2 LC\|no2017136085‏
996		‎‡2 BNF\|17824106‏
996		‎‡2 NTA\|401034658‏
996		‎‡2 ISNI\|0000000046360467‏
996		‎‡2 DNB\|119236419‏
996		‎‡2 ISNI\|0000000356564553‏
996		‎‡2 W2Z\|5053816‏
996		‎‡2 DBC\|87097969439896‏
996		‎‡2 SUDOC\|151611912‏
996		‎‡2 ISNI\|000000044364667X‏
996		‎‡2 J9U\|987007318832705171‏
996		‎‡2 J9U\|987007327584805171‏
996		‎‡2 B2Q\|0000490548‏
996		‎‡2 NKC\|xx0205226‏
996		‎‡2 NII\|DA17972936‏
996		‎‡2 NUKAT\|n 2003090386‏
996		‎‡2 DNB\|128683483X‏
996		‎‡2 J9U\|987008917466505171‏
996		‎‡2 LC\|n 2017053876‏
996		‎‡2 LNB\|LNC10-000288012‏
996		‎‡2 LC\|n 2020041466‏
996		‎‡2 ISNI\|0000000081138482‏
996		‎‡2 ISNI\|0000000083735299‏
996		‎‡2 ISNI\|0000000512764099‏
996		‎‡2 ISNI\|0000000053255956‏
996		‎‡2 LC\|n 82051595‏
996		‎‡2 SUDOC\|143408666‏
996		‎‡2 BNE\|XX4447153‏
996		‎‡2 CAOONL\|ncf11874385‏
996		‎‡2 LC\|n 88122612‏
996		‎‡2 LC\|n 2007087903‏
996		‎‡2 LC\|n 90666545‏
996		‎‡2 LC\|n 90683678‏
996		‎‡2 DNB\|1331625106‏
996		‎‡2 ISNI\|0000000052591368‏
996		‎‡2 DBC\|87097990513540‏
996		‎‡2 BNE\|XX910903‏
996		‎‡2 NUKAT\|n 2016233412‏
996		‎‡2 NKC\|ola20211125866‏
996		‎‡2 ISNI\|0000000031192499‏
996		‎‡2 ISNI\|0000000073065690‏
996		‎‡2 NII\|DA08808862‏
996		‎‡2 LC\|n 90624767‏
996		‎‡2 LC\|no2003006960‏
996		‎‡2 ISNI\|0000000408156720‏
996		‎‡2 ISNI\|0000000396774192‏
996		‎‡2 LC\|n 80036954‏
996		‎‡2 ISNI\|0000000028561804‏
996		‎‡2 CAOONL\|ncf11338397‏
996		‎‡2 BIBSYS\|2099757‏
996		‎‡2 ISNI\|0000000028794966‏
996		‎‡2 DBC\|87097969439888‏
996		‎‡2 VLACC\|000041079‏
996		‎‡2 ISNI\|0000000116955360‏
996		‎‡2 J9U\|987007440480905171‏
996		‎‡2 LC\|no2017005491‏
996		‎‡2 LC\|no2010200818‏
996		‎‡2 SUDOC\|156882027‏
996		‎‡2 ISNI\|0000000046536012‏
996		‎‡2 LC\|no2018124638‏
996		‎‡2 LC\|no2022130855‏
996		‎‡2 ISNI\|0000000067140041‏
996		‎‡2 LC\|no2011152266‏
996		‎‡2 LC\|nb2002052373‏
996		‎‡2 NDL\|031619157‏
996		‎‡2 LC\|n 81080783‏
996		‎‡2 BIBSYS\|5053816‏
996		‎‡2 W2Z\|3026572‏
996		‎‡2 J9U\|987007386325405171‏
996		‎‡2 ISNI\|0000000514185242‏
996		‎‡2 LC\|no2014073133‏
996		‎‡2 PLWABN\|9810656910005606‏
996		‎‡2 BNC\|981058614344706706‏
996		‎‡2 SUDOC\|034603573‏
996		‎‡2 LC\|n 2019067052‏
996		‎‡2 LC\|n 2011014751‏
996		‎‡2 ISNI\|0000000373299851‏
996		‎‡2 NII\|DA17047938‏
996		‎‡2 LC\|no2017168119‏
996		‎‡2 J9U\|987007592444305171‏
996		‎‡2 LC\|no2019022634‏
996		‎‡2 CAOONL\|ncf11316877‏
996		‎‡2 CAOONL\|ncf10175984‏
996		‎‡2 NUKAT\|n 2009053434‏
996		‎‡2 NKC\|xx0176064‏
996		‎‡2 ISNI\|0000000028791407‏
996		‎‡2 DNB\|17151470X‏
996		‎‡2 LC\|no2013044962‏
996		‎‡2 SIMACOB\|66380387‏
996		‎‡2 LC\|no2020025699‏
996		‎‡2 LC\|n 2020030527‏
996		‎‡2 LC\|n 86827129‏
996		‎‡2 DNB\|1261919394‏
996		‎‡2 BNE\|XX1742220‏
996		‎‡2 DBC\|87097969439918‏
996		‎‡2 N6I\|vtls001385748‏
996		‎‡2 CAOONL\|ncf10962479‏
996		‎‡2 ISNI\|0000000081887707‏
996		‎‡2 LC\|no 95052608‏
996		‎‡2 ISNI\|0000000491278680‏
996		‎‡2 PLWABN\|9813663877505606‏
996		‎‡2 DNB\|137919085‏
996		‎‡2 ISNI\|0000000374846298‏
996		‎‡2 NII\|DA16112116‏
996		‎‡2 LC\|n 90707424‏
996		‎‡2 NLA\|000035954855‏
996		‎‡2 CAOONL\|ncf11682632‏
996		‎‡2 DNB\|1042740100‏
996		‎‡2 NKC\|jo20241242175‏
996		‎‡2 ERRR\|12473790‏
996		‎‡2 LC\|n 2009162316‏
996		‎‡2 BIBSYS\|3026572‏
996		‎‡2 N6I\|vtls000365665‏
996		‎‡2 BIBSYS\|1675320984253‏
996		‎‡2 LC\|n 79114526‏
996		‎‡2 PLWABN\|9810683804205606‏
996		‎‡2 ISNI\|000000010853649X‏
996		‎‡2 LC\|no2024100881‏
996		‎‡2 BIBSYS\|6035581‏
996		‎‡2 LC\|n 85007264‏
996		‎‡2 DNB\|1292854162‏
996		‎‡2 LC\|no2024123163‏
996		‎‡2 LC\|no2007101599‏
996		‎‡2 RERO\|A013907607‏
996		‎‡2 LC\|n 82059640‏
996		‎‡2 LC\|n 2010162481‏
996		‎‡2 NTA\|202115704‏
996		‎‡2 LC\|no2011065247‏
996		‎‡2 LC\|n 2022061451‏
996		‎‡2 DNB\|1130735184‏
996		‎‡2 ISNI\|0000000454226793‏
996		‎‡2 LC\|n 99025889‏
996		‎‡2 RERO\|A026136110‏
996		‎‡2 NTA\|288974069‏
996		‎‡2 NDL\|001171231‏
996		‎‡2 LC\|n 2013031569‏
996		‎‡2 NTA\|135356725‏
996		‎‡2 ISNI\|0000000048201427‏
996		‎‡2 ISNI\|0000000082821355‏
996		‎‡2 CAOONL\|ncf11014501‏
996		‎‡2 LC\|n 2014075914‏
996		‎‡2 LC\|n 96103182‏
996		‎‡2 J9U\|987007389580505171‏
996		‎‡2 J9U\|987012726329205171‏
996		‎‡2 SELIBR\|1f74w7k0zgz22w0p‏
996		‎‡2 LC\|n 86114100‏
996		‎‡2 NTA\|427864321‏
996		‎‡2 LIH\|LNB:CKC8;=_s__u_‏
996		‎‡2 ISNI\|0000000027259195‏
996		‎‡2 LC\|no2017125700‏
996		‎‡2 DNB\|1037034945‏
996		‎‡2 ISNI\|0000000438757391‏
996		‎‡2 BIBSYS\|90664889‏
996		‎‡2 LC\|no 97056077‏
996		‎‡2 DNB\|1088807860‏
996		‎‡2 LC\|nb2014028830‏
996		‎‡2 DNB\|140241639‏
996		‎‡2 LIH\|LNB:C_m_IO;=B_e_‏
996		‎‡2 NYNYRILM\|328603‏
996		‎‡2 LC\|no2006004795‏
996		‎‡2 ISNI\|0000000497886599‏
996		‎‡2 LC\|n 92004209‏
996		‎‡2 DNB\|1146706405‏
996		‎‡2 JPG\|500024789‏
996		‎‡2 J9U\|987007351636005171‏
996		‎‡2 LC\|nr 95034476‏
996		‎‡2 LC\|n 96075443‏
996		‎‡2 LC\|nr 96024453‏
996		‎‡2 BNE\|XX5334344‏
996		‎‡2 BNE\|XX4684649‏
996		‎‡2 NUKAT\|n 2017199508‏
996		‎‡2 CAOONL\|ncf13790660‏
996		‎‡2 LC\|nb2003048506‏
996		‎‡2 ISNI\|0000000425795241‏
996		‎‡2 NSK\|000066876‏
996		‎‡2 BNF\|14003452‏
996		‎‡2 NUKAT\|n 2022002594‏
996		‎‡2 DNB\|1172226849‏
996		‎‡2 DNB\|135444217‏
996		‎‡2 NUKAT\|n 2012276452‏
996		‎‡2 J9U\|987007341183705171‏
996		‎‡2 SUDOC\|131021338‏
996		‎‡2 ISNI\|0000000034384963‏
996		‎‡2 LC\|no2007038888‏
996		‎‡2 ISNI\|0000000078917936‏
996		‎‡2 NTA\|074647008‏
996		‎‡2 ISNI\|0000000079881824‏
996		‎‡2 BIBSYS\|90109126‏
996		‎‡2 DE633\|pe30071745‏
996		‎‡2 SUDOC\|069264538‏
997		‎‡a 0 0 lived 0 0‏ ‎‡9 1‏

VIAF

Virtual International Authority File

Search